🔍Diagnostics & Precision Medicine
Molecular diagnostics, companion diagnostics, and precision medicine tools for disease detection and treatment selection.
Market Cap$722.4B
1D+8.72%
Companies2,263
Public Cos51
SECTOR MARKET CAP
$722.4B+19613.1%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Switzerland | $325.4B | ROG.SW |
| 2 |  | United States | $176.2B | TMO |
| 3 |  | United States | $31.5B | A |
| 4 |  | United States | $25.8B | DXCM |
| 5 |  | United States | $21.7B | LH |
| 6 |  | United States | $20.0B | EXAS |
| 7 |  | United States | $19.0B | ILMN |
| 8 |  | United States | $12.8B | MEDP |
| 9 |  | France | $12.4B | BIM.PA |
| 10 |  | United States | $9.6B | RVTY |
| 11 |  | Netherlands | $8.2B | QGEN |
| 12 |  | United States | $8.2B | TEM |
| 13 |  | United States | $8.1B | TECH |
| 14 |  | China | $7.6B | 600196.SS |
| 15 |  | Denmark | $6.4B | ALK-B.CO |
| 16 |  | India | $6.1B | ABBOTINDIA.NS |
| 17 |  | United States | $5.2B | CAI |
| 18 |  | Spain | $2.0B | GRFS |
| 19 |  | Sweden | $1.3B | VITR.ST |
| 20 |  | Japan | $1.1B | 4544.T |